(0.10%) 5 251.50 points
(0.03%) 39 655 points
(0.20%) 18 292 points
(0.00%) $78.26
(0.67%) $2.27
(-0.84%) $2 355.10
(-0.60%) $28.34
(-0.05%) $1 006.70
(-0.01%) $0.928
(0.22%) $10.86
(0.02%) $0.799
(-0.85%) $91.88
@ $14.93
Issued: 14 Feb 2024 @ 14:24
Return: -19.06%
Previous signal: Feb 14 - 12:07
Previous signal:
Return: -1.62 %
Live Chart Being Loaded With Signals
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs...
Stats | |
---|---|
Today's Volume | 217 954 |
Average Volume | 757 237 |
Market Cap | 509.63M |
EPS | $0 ( 2024-03-14 ) |
Next earnings date | ( $-0.690 ) 2024-07-05 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.87 |
ATR14 | $0.0120 (0.10%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-18 | Fairey William | Buy | 17 000 | Stock Option (Right to Buy) |
2024-04-18 | Fairey William | Buy | 0 | |
2024-03-06 | Palleiko Benjamin L | Buy | 250 000 | Restricted Stock Unit |
2024-02-20 | Venrock Healthcare Capital Partners Iii, L.p. | Buy | 655 738 | Pre-Funded Warrants (Right to Buy) |
2024-02-17 | Feener Edward P. | Buy | 18 788 | Common Stock |
INSIDER POWER |
---|
66.06 |
Last 98 transactions |
Buy: 3 056 025 | Sell: 628 012 |
Volume Correlation
Kalvista Pharmaceuticals Correlation
10 Most Positive Correlations | |
---|---|
ACLS | 0.953 |
BWMN | 0.951 |
NVCN | 0.949 |
NVAC | 0.947 |
CRUS | 0.947 |
TETC | 0.947 |
XFIN | 0.946 |
FOCS | 0.944 |
JMAC | 0.943 |
GENQ | 0.941 |
10 Most Negative Correlations | |
---|---|
NAKD | -0.955 |
AMGN | -0.935 |
THMA | -0.932 |
BHTG | -0.93 |
LGMK | -0.926 |
PCSA | -0.925 |
AHPI | -0.924 |
TRIT | -0.918 |
CREG | -0.911 |
PLIN | -0.907 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Kalvista Pharmaceuticals Correlation - Currency/Commodity
Kalvista Pharmaceuticals Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-802 000 (0.00 %) |
EPS: | $-2.68 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-802 000 (0.00 %) |
EPS: | $-2.68 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-743 000 (0.00 %) |
EPS: | $-2.80 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-2.42 |
Financial Reports:
No articles found.
Kalvista Pharmaceuticals
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed a Phase II clinical trial for the treatment of DME; sebetralstat, which is initiation of the Phase 3 KONFIDENT trial as a potential oral, on-demand therapy for HAE attacks; KVD824, an oral product candidate for the treatment of HAE; and Factor XIIa, an oral inhibitor program which is in preclinical stage targets an enzyme in HAE. The company is headquartered in Cambridge, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators